TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.

Shailender Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.